DZ Bank Call 62.5 0B2 20.09.2024/ DE000DQ1WVY4 /
13/05/2024 13:08:25 | Var.0.000 | Denaro13/05/2024 | Lettera13/05/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.220EUR | 0.00% | 0.220 Quantità in denaro: 50,000 |
0.230 Quantità in lettera: 50,000 |
BAWAG GROUP AG | 62.50 EUR | 20/09/2024 | Call |
GlobeNewswire
13:15
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and C...
Newsfile Corp
13:15
Perseverance Metals Strengthens Its Board of Directors, Management and Advisory Teams with the Addit...
GlobeNewswire
13:15
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fis...
GlobeNewswire
13:07
EnviroGold Global Announces the Appointment of Paul McRae as an Independent Director
GlobeNewswire
13:00
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Tr...
GlobeNewswire
13:00
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
13:00
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on Ne...
GlobeNewswire
13:00
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
GlobeNewswire
13:00
Lilium in advanced discussions with French government to expand industrial footprint with high-volum...
GlobeNewswire
13:00
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
13:00
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...